Andy
Retired committee member
Funded study in progress.
Abstract:
Background: Paediatric Chronic Fatigue Syndrome or Myalgic Encaphalistis (CFS/ME) is disabling and relatively common (1-2% of teenagers). We need to improve treatment but need a well developed Patient Reported Outcome Measure (PROM) to do this. Clinical services and randomised controlled trials use a variety of PROMs but they are largely of poor quality with limited relevance to children s experience of CFS/ME. We have completed the first stage in developing a child-centred measure: Prom Evaluating Adolescent and Child cHronic fatigue (PEACH). However, this contains 63 questions and is too long to be used.
Aims: Create a high quality, relevant, acceptable child-reported PROM for paediatric CFS/ME called PEACH-Short form (PEACH-SF). Objective 1: Refine PEACH-63 to construct PEACH-SF.
Objective 2: Check the acceptability and relevance of PEACH-SF. Objective 3: Evaluate the quality, validity, acceptability, reliability and responsiveness of PEACH-SF. Methods: Phase 1:
Objective 1. Refining PEACH-63. We will recruit 313 children from the Bath Specialist paediatric CFS/ME service and the London Specialist paediatric service to complete PEACH-63 once. This will provide data on >250 children. We will collect questionnaire data online and use both traditional and modern psychometric analyses to perform psychometric evaluation. We will describe measurement data quality, the internal structure of the measure, identify those questions which contribute best which will enable us to reduce the number of questions producing PEACH-short form (PEACH-SF), of approximately 20 questions.
Objective 2: We will check the acceptability and relevance of PEACH-SF by interviewing participants (approximately 10) on whether we have retained content and face validity. We will observe approximately 10 children and young people complete PEACH-SF using Usability Testing Software and we will discuss PEACH-SF with the CFS/ME Young Peoples Advisory Group. Phase 2 (Field test 2)
Objective 3. We will recruit a further 313 children and young people (ensuring we have data on >250) to complete PEACH-SF ( approximately 20 questions) at baseline, 2 weeks later (to check temporal stability) and 6 months later (to check measurement responsiveness). We will collect the Clinical Global Improvement Scale (CGI, 1 item) at both time points and the SF-36 physical function short form at 6 months.
Timelines for delivery: Month 10: Field testing 1 complete. Month 14: PEACH-SF complete. Month 28: Field testing 2 complete. Month 31: Psychometric analyses complete and PEACH-SF ready for use. Impact and Dissemination: Short term impact – improved clinical care as PEACH-SF will be used immediately at the end of this study. Medium to long term impact – improved research in paediatric CFS/ME leading to improved treatments.
Dissemination: To ensure PEACH-SF is used throughout the NHS, we will work with the British Association for CFS/ME to disseminate to paediatric CFS/ME services, and the AHSN to disseminate to paediatric services and inform NICE. We will publish, and work with the press office to ensure researchers and the public are aware of PEACH-SF.
Chief Investigator(s):
Professor Esther Crawley
Co-investigators:
Dr Kirstie Haywood, Dr Roxanne Parslow, Dr Terry Segal
Award:
£149,457.00
Start Date:
February 2020
End Date:
September 2022
https://fundingawards.nihr.ac.uk/award/NIHR200509
Abstract:
Background: Paediatric Chronic Fatigue Syndrome or Myalgic Encaphalistis (CFS/ME) is disabling and relatively common (1-2% of teenagers). We need to improve treatment but need a well developed Patient Reported Outcome Measure (PROM) to do this. Clinical services and randomised controlled trials use a variety of PROMs but they are largely of poor quality with limited relevance to children s experience of CFS/ME. We have completed the first stage in developing a child-centred measure: Prom Evaluating Adolescent and Child cHronic fatigue (PEACH). However, this contains 63 questions and is too long to be used.
Aims: Create a high quality, relevant, acceptable child-reported PROM for paediatric CFS/ME called PEACH-Short form (PEACH-SF). Objective 1: Refine PEACH-63 to construct PEACH-SF.
Objective 2: Check the acceptability and relevance of PEACH-SF. Objective 3: Evaluate the quality, validity, acceptability, reliability and responsiveness of PEACH-SF. Methods: Phase 1:
Objective 1. Refining PEACH-63. We will recruit 313 children from the Bath Specialist paediatric CFS/ME service and the London Specialist paediatric service to complete PEACH-63 once. This will provide data on >250 children. We will collect questionnaire data online and use both traditional and modern psychometric analyses to perform psychometric evaluation. We will describe measurement data quality, the internal structure of the measure, identify those questions which contribute best which will enable us to reduce the number of questions producing PEACH-short form (PEACH-SF), of approximately 20 questions.
Objective 2: We will check the acceptability and relevance of PEACH-SF by interviewing participants (approximately 10) on whether we have retained content and face validity. We will observe approximately 10 children and young people complete PEACH-SF using Usability Testing Software and we will discuss PEACH-SF with the CFS/ME Young Peoples Advisory Group. Phase 2 (Field test 2)
Objective 3. We will recruit a further 313 children and young people (ensuring we have data on >250) to complete PEACH-SF ( approximately 20 questions) at baseline, 2 weeks later (to check temporal stability) and 6 months later (to check measurement responsiveness). We will collect the Clinical Global Improvement Scale (CGI, 1 item) at both time points and the SF-36 physical function short form at 6 months.
Timelines for delivery: Month 10: Field testing 1 complete. Month 14: PEACH-SF complete. Month 28: Field testing 2 complete. Month 31: Psychometric analyses complete and PEACH-SF ready for use. Impact and Dissemination: Short term impact – improved clinical care as PEACH-SF will be used immediately at the end of this study. Medium to long term impact – improved research in paediatric CFS/ME leading to improved treatments.
Dissemination: To ensure PEACH-SF is used throughout the NHS, we will work with the British Association for CFS/ME to disseminate to paediatric CFS/ME services, and the AHSN to disseminate to paediatric services and inform NICE. We will publish, and work with the press office to ensure researchers and the public are aware of PEACH-SF.
Chief Investigator(s):
Professor Esther Crawley
Co-investigators:
Dr Kirstie Haywood, Dr Roxanne Parslow, Dr Terry Segal
Award:
£149,457.00
Start Date:
February 2020
End Date:
September 2022
https://fundingawards.nihr.ac.uk/award/NIHR200509